Trial Profile
Double-blind, Three Parallel Randomized Groups, Therapeutic Confirmatory Clinical Trial to Compare the Efficacy of Oral Levocetirizine 5 mg and Montelukast 10 mg to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Ragweed Sensitive Subjects Exposed to Ragweed Pollen in an Environmental Exposure Unit (EEU)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Levocetirizine (Primary) ; Montelukast
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors UCB
- 11 Jul 2007 Status change from in progress to completed.
- 27 Oct 2006 Status change
- 30 Sep 2006 New trial record.